In an age of increasingly bespoke healthcare, Elizabeth Philp has established herself as a significant figure of innovation, especially in the tech-driven field of compounded pharmacy. As the chief executive and co-founder of Roseway Labs, Philp is at the forefront of a drive to make bespoke medications more available, disrupting the standard one-